risperidone has been researched along with glycine in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 7 (50.00) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| McCoy, L; Richfield, EK | 1 |
| Bar, G; Ermilov, M; Heresco-Levy, U; Javitt, DC; Lichtenberg, P | 1 |
| Conn, PJ; Mallorga, PJ; Pettibone, DJ; Sur, C; Williams, JB | 1 |
| Chang, WH; Chang, YC; Hsu, SK; Huang, CH; Lane, HY; Liu, YC | 1 |
| Becker, A; Grecksch, G | 1 |
| Hertel, P; Jardemark, KE; Konradsson, A; Marcus, MM; Svensson, TH | 1 |
| Choi, EY; Joo, YH; Kim, B; Kim, CY; Song, K | 1 |
| Diamant, L; Gaisler-Salomon, I; Rubin, C; Weiner, I | 1 |
| Barkoczy, J; Harsing, LG; Juranyi, Z; Levay, G; Marko, B; Matyus, P; Nagy, K; Pallagi, K; Szabo, G; Zsilla, G | 1 |
| Dolgin, E | 1 |
| Ahmad, MA; Akhtar, M; Kumar, V; Najmi, AK | 1 |
| Firouzabadi, N; Nazariat, A; Zomorrodian, K | 1 |
3 trial(s) available for risperidone and glycine
| Article | Year |
|---|---|
High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia.
Topics: Adult; Antipsychotic Agents; Behavioral Symptoms; Benzodiazepines; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Glycine; Humans; Male; Middle Aged; Multivariate Analysis; Olanzapine; Pirenzepine; Risperidone; Schizophrenia; Serine; Time Factors; Treatment Outcome | 2004 |
Dopamine D3 receptor Ser9Gly polymorphism and risperidone response.
Topics: Adult; Amino Acid Substitution; Antipsychotic Agents; China; DNA; Dose-Response Relationship, Drug; Female; Genotype; Glycine; Humans; Male; Polymorphism, Genetic; Psychiatric Status Rating Scales; Receptors, Dopamine D2; Receptors, Dopamine D3; Risperidone; Schizophrenia; Serine; Social Behavior | 2005 |
Could HTR2A T102C and DRD3 Ser9Gly predict clinical improvement in patients with acutely exacerbated schizophrenia? Results from treatment responses to risperidone in a naturalistic setting.
Topics: Adult; Antipsychotic Agents; Female; Glycine; Humans; Male; Pharmacogenetics; Polymorphism, Genetic; Psychiatric Status Rating Scales; Receptors, Dopamine D3; Receptors, Serotonin, 5-HT2; Risperidone; Schizophrenia; Serine | 2008 |
11 other study(ies) available for risperidone and glycine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Chronic antipsychotic treatment alters glycine-stimulated NMDA receptor binding in rat brain.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Autoradiography; Binding, Competitive; Brain Chemistry; Clozapine; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Glycine; Haloperidol; Male; Pimozide; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Risperidone; Time Factors; Tritium | 1996 |
Effects of typical and atypical antipsychotics on human glycine transporters.
Topics: Amino Acid Transport Systems, Neutral; Animals; Antipsychotic Agents; Benzodiazepines; Brain; Chloride Channels; Choriocarcinoma; Clozapine; Female; Glycine; Glycine Plasma Membrane Transport Proteins; Haloperidol; Humans; Membrane Glycoproteins; Membrane Transport Modulators; Membrane Transport Proteins; Olanzapine; Rats; Receptors, N-Methyl-D-Aspartate; Risperidone; Schizophrenia; Sodium Channels; Synapses; Uterine Neoplasms | 2004 |
Pharmacological treatment to augment hole board habituation in prenatal Vitamin D-deficient rats.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Exploratory Behavior; Female; Glycine; Habituation, Psychophysiologic; Haloperidol; Male; Phenylacetates; Pregnancy; Prenatal Exposure Delayed Effects; Random Allocation; Rats; Risperidone; Vitamin D Deficiency | 2006 |
Inhibition of the glycine transporter GlyT-1 potentiates the effect of risperidone, but not clozapine, on glutamatergic transmission in the rat medial prefrontal cortex.
Topics: Animals; Biological Transport, Active; Clozapine; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Synergism; Excitatory Postsynaptic Potentials; GABA Antagonists; Glutamic Acid; Glycine; Glycine Plasma Membrane Transport Proteins; Male; Organ Culture Techniques; Prefrontal Cortex; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Risperidone; Sarcosine; Synaptic Transmission | 2006 |
Abnormally persistent latent inhibition induced by MK801 is reversed by risperidone and by positive modulators of NMDA receptor function: differential efficacy depending on the stage of the task at which they are administered.
Topics: Animals; Behavior, Animal; Clozapine; Conditioning, Psychological; Cycloserine; Dizocilpine Maleate; Dose-Response Relationship, Drug; Emotions; Fluorobenzenes; Glycine; Glycine Agents; Inhibition, Psychological; Male; Piperidines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Receptors, Serotonin; Risperidone; Serotonin Antagonists; Stress, Psychological; Thirst; Treatment Outcome | 2008 |
Alterations in brain extracellular dopamine and glycine levels following combined administration of the glycine transporter type-1 inhibitor Org-24461 and risperidone.
Topics: Animals; Corpus Striatum; Dopamine; Extracellular Space; Glycine; Glycine Plasma Membrane Transport Proteins; Male; Microdialysis; Protein Binding; Rats; Risperidone; Sarcosine | 2010 |
Therapeutics: Negative feedback.
Topics: Affect; alpha7 Nicotinic Acetylcholine Receptor; Antipsychotic Agents; Controlled Clinical Trials as Topic; Electric Stimulation Therapy; Glutamic Acid; Glycine; Glycine Plasma Membrane Transport Proteins; Happiness; Humans; Piperazines; Pleasure; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulfones; Treatment Failure | 2014 |
Effect of Sarcosine (a Glycine Transport 1 Inhibitor) and Risperidone (an Atypical antipsychotic Drug) on MK-801 Induced Learning and Memory Deficits in Rats.
Topics: Animals; Antipsychotic Agents; Dizocilpine Maleate; gamma-Aminobutyric Acid; Glycine; Glycine Plasma Membrane Transport Proteins; Learning Disabilities; Male; Memory Disorders; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Risperidone; Sarcosine; Serotonin | 2016 |
DRD3 Ser9Gly Polymorphism and Its Influence on Risperidone Response in Autistic Children.
Topics: Adolescent; Alleles; Autistic Disorder; Child; Child, Preschool; Female; Genotype; Glycine; Humans; Iran; Male; Polymorphism, Genetic; Receptors, Dopamine D3; Risperidone; Serine; Software; Treatment Outcome | 2017 |